Rossi Michael J — SEC Form 4 filings

SEC reporting owner CIK 1948795. 4 Form 4 filings on record with FilingPulse; latest filed 2025-09-18.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-14 to 2025-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Y-mAbs Therapeutics, Inc. (YMAB)PRESIDENT & CEO, Director41 leg · 3,917 sh · $20,36815

Form 4 filings — Rossi Michael J

FiledFormIssuerReported transactionsSource
2025-09-184Y-mAbs Therapeutics, Inc. (YMAB)Code (U): 7,982 @ $8.60 · Disposition to issuer (D): 129,101 · Disposition to issuer (D): 615,240 (derivative) · Disposition to issuer (D): 214,200 (derivative) · Disposition to issuer (D): 210,700 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +4 moreEDGAR
2025-03-114Y-mAbs Therapeutics, Inc. (YMAB)Sale (S): 3,917 @ $5.20EDGAR
2025-01-224Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 105,300 @ $0 · Grant/award (A): 210,700 (derivative) @ $0EDGAR
2024-02-144Y-mAbs Therapeutics, Inc. (YMAB)Grant/award (A): 35,700 @ $0 · Grant/award (A): 214,200 (derivative) @ $0 · Grant/award (A): 54,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1948795 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →